Skip to main content
Log in

Pulmonary Cavernous Hemangiomatosis Treated with Interferon Alfa-2a

  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Pulmonary hemangiomatosis is a rare, usually fatal disorder characterized by diffuse proliferation of blood vessels within the thorax. We describe a 7-year-old boy with cavernous-type pulmonary hemangiomatosis successfully treated with interferon alfa-2a. He presented with respiratory distress and hemoptysis that were alleviated during a 2-year follow-up period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, JM., Lin, CS., Wang, JN. et al. Pulmonary Cavernous Hemangiomatosis Treated with Interferon Alfa-2a. Pediatr Cardiol 17, 332–334 (1996). https://doi.org/10.1007/s002469900074

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002469900074

Navigation